Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
09/2005
09/07/2005EP1569915A2 Spirocyclic ureas, compositions containing such compounds and methods of use
09/07/2005EP1569912A2 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005EP1458717B1 Aroyl pyridinones
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1187812B1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
09/07/2005CN1665816A Novel diketopyrrolopyrrole pigments
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1217940C Naphthol derivatives
09/07/2005CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
09/07/2005CN1217931C Spirocyclic phenyl keto-enols as pesticides and herbicides
09/07/2005CN1217660C IL-8 receptor antagonists
09/06/2005US6939887 Nitrogen compounds such as 3-[2-(diethylamino)ethyl]-1-(2-methylbenzyl)-2-oxo-7-(trifluoromethyl)-2,3-dihydro-1H-benzimidazole-5-carboxamide trifluoroacetate, used as somatoliberins
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/01/2005WO2005080348A1 Novel sulfone amide derivative
09/01/2005WO2005080334A1 Novel heterocyclic compound
09/01/2005WO2005080330A1 Heteroarylphenylurea derivative
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005WO2005079866A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005WO2005079865A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005WO2005079791A1 Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
09/01/2005US20050192328 Compounds and methods for use thereof in the treatment of viral infections
09/01/2005DE102004008141A1 Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren Guanidine compounds and their use as binding partners for 5-HT5 receptors
09/01/2005CA2555970A1 Therapeutic amide derivatives
09/01/2005CA2555963A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005CA2555959A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005CA2555409A1 Novel sulfone amide derivative
09/01/2005CA2554774A1 Novel heterocyclic compound
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1567525A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
08/31/2005EP1567494A1 Methods for preparing phenylalkyne derivatives
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005CN1662215A Benzoxazole and benzodiazole UV-A sunscreens
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/30/2005US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/30/2005US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2004108687A3 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
08/25/2005WO2004106493A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/25/2005WO2004069394A3 Synthetic method for direct arylation of heterocyclic arenes
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005CA2555827A1 Tricyclic imidazopyridines and intermediates for the synthesis thereof
08/24/2005EP1566381A1 Process for production of 1- 2-(benzimidazol-2-yl- thio)ethyl ]piperazine or salts thereof
08/24/2005EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
08/24/2005EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1659136A Novel sodium channel blockers
08/24/2005CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
08/24/2005CN1658759A Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1216018C Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
08/23/2005US6933390 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
08/18/2005WO2005075436A2 Novel inhibitors of glutaminyl cyclase
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005042559A9 Capture and release based isotope tagged peptides and methods for using the same
08/18/2005WO2005021547A3 Heterocyclic cannabinoid cb2 receptor antagonists
08/18/2005CA2554809A1 Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/16/2005US6930121 Benzimidazole derivatives and salts and prodrugs thereof; treatment of cancers or viral infections
08/11/2005WO2005073180A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative
08/11/2005WO2005044807A3 Benzoimidazole compounds
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2005003081B1 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells
08/11/2005US20050176797 Thromboembolic disorders; e.g. 2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-5'-fluoro-6,2'-dihydroxy-biphenyl-3-yl]-succinic acid
08/11/2005US20050176792 2-arylcarbonylamino-4,5,6 or 7-(keto(alkyl))-benzimidazoles; cancer, inflammation, immunological disorders and allergic disorders
08/11/2005US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one
08/10/2005EP1561741A1 Method for deuteration or tritiation of heterocyclic ring
08/10/2005EP1561463A2 Benzamidoxime prodrugs as antipneumocystic agents
08/10/2005EP1515956A4 Peptide deformylase inhibitors
08/10/2005EP1292581B1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653053A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652792A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/09/2005CA2256687C Benzimidazole derivatives for treating gastrointestinal inflammatory diseases
08/04/2005WO2005070920A1 Amino-benzazoles as p2y1 receptor inhibitors
08/04/2005WO2005070906A1 Organic compounds
08/04/2005WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
08/04/2005WO2005070420A1 1h-benzimidazol-2-yl-benzamide derivatives and related compounds as itk inhibitors (interleukin-2-inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171204 2S)-3-(4-{2-[(Cyclohexylmethyl)(heptyl)amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid; treating lipid disorders (dyslipidemias), insulin resistance
08/04/2005US20050171175 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005CA2553966A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553009A1 Organic compounds
08/03/2005EP1558341A2 Transcription factor modulating compounds and methods of use thereof
08/03/2005EP1558248A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068433A1 Benzimidazole derivatives
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 154